Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes

Shi Chung Chen, Jun Jack Cheng, Ming Hsiung Hsieh, Yen Ling Chu, Pai Feng Kao, Tzu-Hurng Cheng, Paul Chan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Trilinolein, isolated from the traditional Chinese herb Sanchi (Panax notoginseng), has been shown to have myocardial protective effects via its antioxidant ability. However, the cellular and molecular mechanisms of the protective effect of trilinolein in the heart remain to be elucidated. Oxidative mechanisms have been implicated in neonatal cardiomyocyte hypertrophy. We therefore have examined whether trilinolein attenuates reactive oxygen species (ROS) production and thus ET-1-induced hypertrophy of cardiomyocytes, Cultured neonatal rat cardiomyocytes were stimulated with ET-1 (10 nM), [ 3H]leucine incorporation and the β-myosin heavy chain (β-MyHC) promoter activity were examined. Trilinolein (1 and 10 μM) inhibited the ET-1-induced increase of [3H]-leucine incorporation in a concentration-dependent manner. Trilinolein (1 and 10 μM) also inhibited ET-1-induced β-MyHC promoter activity in cardiomyocytes. We further examined the effects of trilinolein on ET-1-induced intracellular ROS generation by measuring a redox-sensitive fluorescent dye, 2′,7′- dichlorofluorescin diacetate, fluorescence intensity. Trilinolein (1 and 10 μM) inhibited ET-1-increased intracellular ROS levels in a concentration-dependent manner. This increase of ROS by ET-1 (10 μM) or H2O2 (25 μM) was significantly inhibited by trilinolein (10 μM) and N-acetylcysteine (10 mM). Moreover, ET-1-or H2O 2-induced β-MyHC promoter activity and protein synthesis were also inhibited by trilinolein (10 μM). These data indicate that trilinolein inhibits ET-1-induced β-MyHC promoter activity, and subsequent hypertrophy via its antioxidant ability in cardiomyocytes.

Original languageEnglish
Pages (from-to)525-529
Number of pages5
JournalPlanta Medica
Volume71
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

endothelins
Endothelin-1
hypertrophy
Cardiac Myocytes
Hypertrophy
Rats
neonates
reactive oxygen species
promoter regions
leucine
protective effect
Reactive Oxygen Species
Panax notoginseng
antioxidants
acetylcysteine
myosin heavy chains
fluorescent dyes
Leucine
herbs
Antioxidants

Keywords

  • Cardiomyocyte hypertrophy
  • Endothelin-1
  • Reactive oxygen species
  • Trilinolein

ASJC Scopus subject areas

  • Plant Science
  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes. / Chen, Shi Chung; Cheng, Jun Jack; Hsieh, Ming Hsiung; Chu, Yen Ling; Kao, Pai Feng; Cheng, Tzu-Hurng; Chan, Paul.

In: Planta Medica, Vol. 71, No. 6, 06.2005, p. 525-529.

Research output: Contribution to journalArticle

@article{efbfa39030084e5591de3387ffcc20e3,
title = "Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes",
abstract = "Trilinolein, isolated from the traditional Chinese herb Sanchi (Panax notoginseng), has been shown to have myocardial protective effects via its antioxidant ability. However, the cellular and molecular mechanisms of the protective effect of trilinolein in the heart remain to be elucidated. Oxidative mechanisms have been implicated in neonatal cardiomyocyte hypertrophy. We therefore have examined whether trilinolein attenuates reactive oxygen species (ROS) production and thus ET-1-induced hypertrophy of cardiomyocytes, Cultured neonatal rat cardiomyocytes were stimulated with ET-1 (10 nM), [ 3H]leucine incorporation and the β-myosin heavy chain (β-MyHC) promoter activity were examined. Trilinolein (1 and 10 μM) inhibited the ET-1-induced increase of [3H]-leucine incorporation in a concentration-dependent manner. Trilinolein (1 and 10 μM) also inhibited ET-1-induced β-MyHC promoter activity in cardiomyocytes. We further examined the effects of trilinolein on ET-1-induced intracellular ROS generation by measuring a redox-sensitive fluorescent dye, 2′,7′- dichlorofluorescin diacetate, fluorescence intensity. Trilinolein (1 and 10 μM) inhibited ET-1-increased intracellular ROS levels in a concentration-dependent manner. This increase of ROS by ET-1 (10 μM) or H2O2 (25 μM) was significantly inhibited by trilinolein (10 μM) and N-acetylcysteine (10 mM). Moreover, ET-1-or H2O 2-induced β-MyHC promoter activity and protein synthesis were also inhibited by trilinolein (10 μM). These data indicate that trilinolein inhibits ET-1-induced β-MyHC promoter activity, and subsequent hypertrophy via its antioxidant ability in cardiomyocytes.",
keywords = "Cardiomyocyte hypertrophy, Endothelin-1, Reactive oxygen species, Trilinolein",
author = "Chen, {Shi Chung} and Cheng, {Jun Jack} and Hsieh, {Ming Hsiung} and Chu, {Yen Ling} and Kao, {Pai Feng} and Tzu-Hurng Cheng and Paul Chan",
year = "2005",
month = "6",
doi = "10.1055/s-2005-864153",
language = "English",
volume = "71",
pages = "525--529",
journal = "Planta Medica",
issn = "0032-0943",
publisher = "Georg Thieme Verlag",
number = "6",

}

TY - JOUR

T1 - Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes

AU - Chen, Shi Chung

AU - Cheng, Jun Jack

AU - Hsieh, Ming Hsiung

AU - Chu, Yen Ling

AU - Kao, Pai Feng

AU - Cheng, Tzu-Hurng

AU - Chan, Paul

PY - 2005/6

Y1 - 2005/6

N2 - Trilinolein, isolated from the traditional Chinese herb Sanchi (Panax notoginseng), has been shown to have myocardial protective effects via its antioxidant ability. However, the cellular and molecular mechanisms of the protective effect of trilinolein in the heart remain to be elucidated. Oxidative mechanisms have been implicated in neonatal cardiomyocyte hypertrophy. We therefore have examined whether trilinolein attenuates reactive oxygen species (ROS) production and thus ET-1-induced hypertrophy of cardiomyocytes, Cultured neonatal rat cardiomyocytes were stimulated with ET-1 (10 nM), [ 3H]leucine incorporation and the β-myosin heavy chain (β-MyHC) promoter activity were examined. Trilinolein (1 and 10 μM) inhibited the ET-1-induced increase of [3H]-leucine incorporation in a concentration-dependent manner. Trilinolein (1 and 10 μM) also inhibited ET-1-induced β-MyHC promoter activity in cardiomyocytes. We further examined the effects of trilinolein on ET-1-induced intracellular ROS generation by measuring a redox-sensitive fluorescent dye, 2′,7′- dichlorofluorescin diacetate, fluorescence intensity. Trilinolein (1 and 10 μM) inhibited ET-1-increased intracellular ROS levels in a concentration-dependent manner. This increase of ROS by ET-1 (10 μM) or H2O2 (25 μM) was significantly inhibited by trilinolein (10 μM) and N-acetylcysteine (10 mM). Moreover, ET-1-or H2O 2-induced β-MyHC promoter activity and protein synthesis were also inhibited by trilinolein (10 μM). These data indicate that trilinolein inhibits ET-1-induced β-MyHC promoter activity, and subsequent hypertrophy via its antioxidant ability in cardiomyocytes.

AB - Trilinolein, isolated from the traditional Chinese herb Sanchi (Panax notoginseng), has been shown to have myocardial protective effects via its antioxidant ability. However, the cellular and molecular mechanisms of the protective effect of trilinolein in the heart remain to be elucidated. Oxidative mechanisms have been implicated in neonatal cardiomyocyte hypertrophy. We therefore have examined whether trilinolein attenuates reactive oxygen species (ROS) production and thus ET-1-induced hypertrophy of cardiomyocytes, Cultured neonatal rat cardiomyocytes were stimulated with ET-1 (10 nM), [ 3H]leucine incorporation and the β-myosin heavy chain (β-MyHC) promoter activity were examined. Trilinolein (1 and 10 μM) inhibited the ET-1-induced increase of [3H]-leucine incorporation in a concentration-dependent manner. Trilinolein (1 and 10 μM) also inhibited ET-1-induced β-MyHC promoter activity in cardiomyocytes. We further examined the effects of trilinolein on ET-1-induced intracellular ROS generation by measuring a redox-sensitive fluorescent dye, 2′,7′- dichlorofluorescin diacetate, fluorescence intensity. Trilinolein (1 and 10 μM) inhibited ET-1-increased intracellular ROS levels in a concentration-dependent manner. This increase of ROS by ET-1 (10 μM) or H2O2 (25 μM) was significantly inhibited by trilinolein (10 μM) and N-acetylcysteine (10 mM). Moreover, ET-1-or H2O 2-induced β-MyHC promoter activity and protein synthesis were also inhibited by trilinolein (10 μM). These data indicate that trilinolein inhibits ET-1-induced β-MyHC promoter activity, and subsequent hypertrophy via its antioxidant ability in cardiomyocytes.

KW - Cardiomyocyte hypertrophy

KW - Endothelin-1

KW - Reactive oxygen species

KW - Trilinolein

UR - http://www.scopus.com/inward/record.url?scp=21344449545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344449545&partnerID=8YFLogxK

U2 - 10.1055/s-2005-864153

DO - 10.1055/s-2005-864153

M3 - Article

VL - 71

SP - 525

EP - 529

JO - Planta Medica

JF - Planta Medica

SN - 0032-0943

IS - 6

ER -